Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Oil Higher On Pfizer Report, Gold Hovers

Published 12/08/2021, 11:31 PM
Updated 03/05/2019, 07:15 AM

Oil rises on Omicron optimism

Crude prices got an early boost after another round of Pfizer (NYSE:PFE) vaccine data that allayed fears of lockdowns.

Despite all the optimism over vaccine efficacy against Omicron, travel has taken a big hit across Europe and that might not improve until cases decline and governments no longer need to consider new restrictions. Switzerland saw a record high in cases, the UK reported 51,342 new infections, and France registered a surge in COVID hospitalizations.

WTI crude did not know how to react to a mixed EIA report. A small draw was accompanied with slightly higher production, limited Omicron impact with gasoline consumption, but softer jet fuel demand and a decline with exports.

Gold awaits US inflation report

Gold remains anchored until the US inflation report on Friday. Gold gave up earlier gains after the highly anticipated Pfizer announcement showed its booster dose gives a high level of protection against the Omicron variant in a new study. The yield curve is steepening as haven bids ease. The short-end of the curve saw the 2-year tentatively reach 0.70% before settling back towards 0.681%.

Gold will shortly be breaking out off its USD1770 to USD 1795 trading range once the latest inflation report tells investors if they should ramp up their hawkish Fed bets.

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.